注射笔市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPRE00002867
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 170
Buy Now

注射笔市场预计将从 2021 年的 372.6135 亿美元增至 2028 年的 603.3297 亿美元;预计 2022 年至 2028 年复合年增长率为 7.14%。

注射笔是一种借助针头将药物注射到皮下的医疗设备。该产品于20世纪80年代首次使用,注射笔是日常注射器的最佳替代品之一。这些产品专为视力不佳、能力有限、在某些条件下自我药疗等人士而设计。目前,注射笔主要用于胰岛素注射。注射笔有时也称为胰岛素笔。这些注射笔的销量已经超过了用于治疗 2 型糖尿病的胰岛素注射瓶的销量。

注射笔市场按类型、疗法、最终用户和地理位置进行细分。按地域划分,注射笔市场大致分为北美、欧洲、亚太地区、中东和亚洲。非洲和南方和南方。中美洲。该报告提供了深入的市场信息和分析,强调市场趋势、技术进步和市场动态等参数,以及全球领先市场参与者的竞争格局分析。

注射笔市场:战略洞察

注射笔市场利润丰厚的区域

市场前景

战略增长发展

注射笔市场的特点是存在多个市场参与者。为了增加市场份额,市场参与者采取各种策略,例如产品发布、区域扩张和技术进步。注射笔更多地参与不断的创新和技术进步,导致行业参与者的接受度更高。主要参与者投资研发以开发先进技术并赚取更多收入。

与注射笔相关的一些最新进展如下:

    < li class= "tox-checklist--checked">2022 年 5 月,FDA 批准了礼来公司的 Mounjaro 注射液,这是第一个也是唯一一个葡萄糖依赖性促胰岛素多肽 (GIP) 和胰高血糖素样肽受体激动剂 -1 (GLP-1),用于治疗成人 2 型糖尿病。 Mounjaro 有六种规格(2.5 毫克、5 毫克、7.5 毫克、10 毫克、12.5 毫克和 15 毫克),采用礼来著名的自动注射笔,配有预装的隐藏针头。
  • 2022 年 1 月,SHL Medical 与 Innovation Zed 合作开发互联笔式注射器解决方案。推出了 InsulCheck DOSE,这是一款联网配套设备,可将传统笔式注射器转变为智能解决方案,以支持疾病管理方案监测。
  • 2021 年 11 月,赛诺菲和罗氏合作,在法国共同努力,增加一次性胰岛素笔连接附加装置的采用。合作伙伴将共同开发针对医生和药剂师的科学教育计划。
  • 2021 年 9 月,BIOCORP 和诺和诺德通过一项关于智能传感器的新协议加强了合作伙伴关系Mallya 与诺和诺德 FlexTouch 胰岛素笔。名为 Mallya 的智能传感器直接连接到诺和诺德 FlexTouch 胰岛素笔。借助 Mallya,使用 FlexTouch 笔的患者将能够捕获和记录每日胰岛素注射数据,包括胰岛素单位以及给药日期和时间。根据协议,诺和诺德将从 2023 年上半年开始在日本将 Mallya 商业化。
  • 2021 年 5 月,礼来公司与领先的糖尿病技术公司开展国际合作,为糖尿病患者集成互联胰岛素笔解决方案。公司与四家公司DexCom, Inc.签署了战略国际协议;格洛克公司;我的迪亚比医疗保健;与罗氏合作推广互联解决方案并优化对糖尿病患者的护理。

因此,上述所有近期发展都在推动注射笔市场的增长。

ul>

因此,上述所有最新发展正在推动注射笔市场的增长。

p>

生物制剂专利到期日和生物仿制药的使用增加

p>

h3>

生物制剂被广泛开发用于治疗癌症、多发性硬化症和糖尿病等慢性疾病。这些药物各具特色,制造商拥有 20 年的制造和分销这些药物的专利。由于大多数专利已经过期或即将过期,市场上的其他参与者已经开始推出自己的此类药物版本,即生物仿制药。近年来,生物仿制药(政府和保险公司首选的低价仿制药)比原研生物制剂获得了巨大的吸引力。制药市场参与者正在推动生物仿制药的采用,这进一步创造了对其给药注射笔的需求。据 AJMC 称,截至 2022 年 12 月,美国共有 40 种生物仿制药获得批准,并已推出 25 种新的生物仿制药。此外,由于快速反应,注射笔的需求已大幅增加,从而推动了注射笔的需求

此外,注射笔制造商不断提供正确使用注射笔的培训,以避免相关危险,例如针刺伤和高血糖,这有望为注射笔市场创造机会。例如,Aptar Pharma 旗下的 Noble 是医疗设备培训解决方案领域的全球领导者,通过开发以患者为中心的给药培训设备(包括注射器、自动注射器、预充式注射器等)来改善患者体验和结果。因此,生物仿制药的使用增加、专利到期和注射剂使用的增加可能会在未来几年为注射笔市场的增长创造充足的机会。

技术进步和医疗废物减少

< p>各种市场参与者在全球范围内开展业务,并正在努力获得重要的市场份额。注射笔用于治疗各种慢性疾病(例如癌症、糖尿病、心血管疾病和多发性硬化症)的使用显着增长。家庭医疗保健的兴起进一步推动了对注射笔的需求。这推动了注射笔的技术进步。制造商专注于开发下一代智能胰岛素笔以提供计量剂量的胰岛素。例如,Medtronic plc 推出了集成了实时 CGM Guardian Connect 数据的 InPen。 InPen 是市场上第一款也是唯一一款经 FDA 批准用于每日多次注射 (MDI) 的人的智能胰岛素笔。该集成系统提供实时血糖读数以及胰岛素剂量信息,为用户提供在单一视图中管理糖尿病所需的一切。用户无需在应用程序之间切换,而是可以在一个视图中实时查看所有必需的信息,从而更轻松地做出更明智的剂量决策来控制血糖水平。此外,人工智能的使用将改变游戏规则,因为它将跟踪药物或胰岛素的剂量、日期和时间,这从长远来看将是有益的,并且有助于各种病症的治疗和管理。

用于注射胰岛素和其他注射剂的传统注射器每天会给患者带来痛苦和不舒服,此外还会产生大量医疗废物。大约 73% 的胰岛素浪费与传统技术的使用有关。使用注射笔后,这种浪费减少到 3.6%,效果显着。因此,技术进步和减少医疗废物的需求不断增长是注射笔市场的趋势之一。

基于治疗的信息

基于治疗,全球注射笔市场被细分如糖尿病治疗、生长激素治疗、自身免疫性疾病治疗、生育治疗、癌症治疗和其他治疗。糖尿病治疗细分市场在 2021 年占据最大的市场份额。其他治疗细分市场预计在预测期内将以最高复合年增长率增长。其他疗法包括偏头痛治疗。偏头痛是一种神经系统疾病,会导致中度至重度头痛。例如,根据 Healthline Media UK Ltd 在媒体上发表的估计,偏头痛很常见,影响着美国 3900 万人和全球 10 亿人。因此,用笔进行偏头痛自我注射,一个人可以自行注射通过将偏头痛药物插入皮下组织来治疗偏头痛。这些笔的使用可能是预防性的,并且含有药物以减少偏头痛发作的频率和严重程度,或有助于缓解偏头痛的急性发作。这些显着的发展将加速人们对自动注射笔的整体需求,推动预测期内市场的增长。

注射笔市场,由 Therapy 提供 - 2021年和2028年

产品发布、并购是全球注射笔市场参与者高度采用的策略。下面列出了近期的一些关键产品开发:

  • 2021 年 5 月,礼来公司与糖尿病领域的技术领导者开展国际合作。公司为糖尿病患者集成互联胰岛素笔解决方案。该公司与 DexCom, Inc.、Glooko Inc.、myDiabby Healthcare 和罗氏四家公司签署了战略国际协议,以推进互联解决方案并优化对糖尿病患者的护理。
  • 2021 年 9 月,BIOCORP 和诺和诺德就 Mallya 智能传感器与诺和诺德 FlexTouch 胰岛素笔达成了新协议,加强了合作伙伴关系。名为 Mallya 的智能传感器直接连接到诺和诺德 FlexTouch 胰岛素笔。借助 Mallya,使用 FlexTouch 笔的患者将能够捕获和记录每日胰岛素注射数据,包括胰岛素单位以及给药日期和时间。根据协议,诺和诺德将于 2023 年上半年开始在日本销售 Mallya。

注射笔市场:细分

根据类型,注射笔注射 市场分为一次性注射笔和可重复使用注射笔。按治疗方法,市场分为糖尿病、生长激素治疗、自身免疫性疾病、生育、癌症等。就最终用户而言,市场分为医院和诊所、家庭护理等。根据地理位置,注射笔市场分为北美(美国、加拿大、墨西哥)、欧洲(法国、德国、英国、意大利、西班牙和欧洲其他地区)、亚太地区(中国、日本、印度)。 、澳大利亚、韩国和亚太地区其他地区)、中东和亚洲。非洲(沙特阿拉伯、南非、阿拉伯联合酋长国以及中东和非洲其他地区)、南非和非洲。中美洲(巴西、阿根廷以及中南美洲其他地区)。

注射笔市场:公司简介

  • Eli Lilly and Co
  • 诺和诺德公司
  • 欧文·芒福德有限公司
  • 赛诺菲公司
  • 默克公司
  • Haselmeier GmbH
  • Gerresheimer AG< /li>
  • Becton Dickinson and Co
  • 阿斯利康公司
  • 梯瓦制药工业有限公司
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are Injection Pens?

An injection pen is a medical device used for incorporating medicine under the skin with the help of a needle. The product was first used in medical history in the 1980s. An injection pen is one of the good alternatives to the daily syringe. The products are designed for individuals with poor vision, limited skill, self-medication in a certain condition, and others. At, present products are majorly used for insulin administration. Sometimes injection pens are also referred to as Insulin pens. These products surpassed in sales for insulin administration for diabetes type 2 patients compared with vials in the United States. The product is also used to administer the drug hormonal therapy, for cancer and arthritis.

What are the driving factors for the Injection Pen market across the globe?

Key factors that are driving the growth of the market are the increasing prevalence of chronic disorders like Diabetes, Cancer, Arthritis, Hormonal disorders, and others. In addition, the growing adoption of technologies fuels the growth of the market. However, risks, complications, and injecting errors associated with an injection pen is expected to restrict the market growth during the forecast period.

What will be the CAGR of the Injection Pen market?

The Injection Pen market is anticipated to grow around 7.2% CAGR amid the forecast period 2022-2028.

Which region is projected to be the fastest-growing region in the global Injection Pen market?

Asia Pacific is projected to be the fastest-growing region in the global market.

What is the cost of an Injection Pen?

The costs of the Injection Pen are much higher, and they may cost US$ 6–60, or more, per type. The cost may also differ from product-to-product types.

The List of Companies - Injection Pens Market

  1. Novo Nordisk A/S
  2. Novartis AG
  3. Eli Lilly
  4. Merck KGaA
  5. Wilhelm Haselmeier GmbH & Co. KG
  6. Astrazeneca
  7. F.Hoffman-La-Roche
  8. BD
  9. Pfizer
  10. Teva Pharmaceutical Industries Ltd.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports